Yale Launches National Study of Personalized Medicine for Metastatic Melanoma
Yale Cancer Center/Smilow Cancer HospitalYale University has launched a multicenter clinical trial, sponsored by Stand Up to Cancer and Melanoma Research Alliance, that will apply the latest in personalized medicine technology to treat metastatic melanoma. The trial, for which Yale is a lead site, will enroll patients lacking a particular genetic mutation for whom immune therapy did not work or was not an option.